Industry · The Decoder ·
Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable
Anthropic is launching drug development programs focused on neglected diseases that large pharmaceutical companies often avoid because they are unprofitable. The article also cites Novartis CEO Vas Narasimhan, who said AI could shorten drug development timelines and improve success rates.